Evidence of association of the NLRP1 gene with giant cell arteritis

Recent studies have focused attention on the involvement of NLRP1 to confer susceptibility for extended autoimmune/inflammatory disorders, being considered a common risk factor in autoimmunity. NLRP1 provides a scaffold for the assembly of the inflammasome that activates caspases 1 and 5, required for processing and activation of the proinflammatory cytokines interleukin 1β (IL-1β), IL-18 and IL-33 and promoting inflammation

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

Objective: To analyse the role of the PTPN22 and CSK genes, previously associated with autoimmunity, in the predisposition and clinical phenotypes of giant cell arteritis (GCA). Methods: Our study population was composed of 911 patients diagnosed with biopsy-proven GCA and 8136 unaffected controls from a Spanish discovery cohort and three additional independent replication cohorts from Germany, Norway and the UK. Two functional PTPN22 polymorphisms (rs2476601/R620W and rs33996649/R263Q) and two variants of the CSK gene (rs1378942 and rs34933034) were genotyped using predesigned TaqMan assays. Results: The analysis of the discovery cohort provided evidence of association of PTPN22 rs2476601/R620W with GCA (PFDR=1.06E-04, OR=1.62, CI 95% 1.29 to 2.04). The association did not appear to follow a specific GCA subphenotype. No statistically significant differences between allele frequencies for the other PTPN22 and CSK genetic variants were evident either in the case/control or in stratified case analysis. To confirm the detected PTPN22 association, three replication cohorts were genotyped, and a consistent association between the PTPN22 rs2476601/R620W variant and GCA was evident in the overall meta-analysis (PMH=2.00E-06, OR=1.51, CI 95% 1.28 to 1.79). Conclusions: Our results suggest that the PTPN22 polymorphism rs2476601/R620W plays an important role in the genetic risk to GCA

Analysis of the common genetic component of large-vessel vasculitides through a meta- Immunochip strategy

Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are major forms of large-vessel vasculitis (LVV) that share clinical features. To evaluate their genetic similarities, we analysed Immunochip genotyping data from 1,434 LVV patients and 3,814 unaffected controls. Genetic pleiotropy was also estimated. The HLA region harboured the main disease-specific associations. GCA was mostly associated with class II genes (HLA-DRB1/HLA-DQA1) whereas TAK was mostly associated with class I genes (HLA-B/MICA). Both the statistical significance and effect size of the HLA signals were considerably reduced in the cross-disease meta-analysis in comparison with the analysis of GCA and TAK separately. Consequently, no significant genetic correlation between these two diseases was observed when HLA variants were tested. Outside the HLA region, only one polymorphism located nearby the IL12B gene surpassed the study-wide significance threshold in the meta-analysis of the discovery datasets (rs755374, P?=?7.54E-07; ORGCA?=?1.19, ORTAK?=?1.50). This marker was confirmed as novel GCA risk factor using four additional cohorts (PGCA?=?5.52E-04, ORGCA?=?1.16). Taken together, our results provide evidence of strong genetic differences between GCA and TAK in the HLA. Outside this region, common susceptibility factors were suggested, especially within the IL12B locus

A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis

Giant cell arteritis (GCA) is the most common form of vasculitis in individuals older than 50 years in Western countries. To shed light onto the genetic background influencing susceptibility for GCA, we performed a genome-wide association screening in a well-powered study cohort. After imputation, 1,844,133 genetic variants were analysed in 2,134 cases and 9,125 unaffected controls from ten independent populations of European ancestry. Our data confirmed HLA class II as the strongest associated region (independent signals: rs9268905, P = 1.94E-54, per-allele OR = 1.79; and rs9275592, P = 1.14E-40, OR = 2.08). Additionally, PLG and P4HA2 were identified as GCA risk genes at the genome-wide level of significance (rs4252134, P = 1.23E-10, OR = 1.28; and rs128738, P = 4.60E-09, OR = 1.32, respectively). Interestingly, we observed that the association peaks overlapped with different regulatory elements related to cell types and tissues involved in the pathophysiology of GCA. PLG and P4HA2 are involved in vascular remodelling and angiogenesis, suggesting a high relevance of these processes for the pathogenic mechanisms underlying this type of vasculitis

A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic immune-mediated vasculitis. A case-control cohort, comprising 1,651 case subjects with GCA and 15,306 unrelated control subjects from six different countries of European ancestry, was genotyped by the Immunochip array. We also imputed HLA data with a previously validated imputation method to perform a more comprehensive analysis of this genomic region. The strongest association signals were observed in the HLA region, with rs477515 representing the highest peak (p = 4.05 × 10−40, OR = 1.73). A multivariate model including class II amino acids of HLA-DRβ1 and HLA-DQα1 and one class I amino acid of HLA-B explained most of the HLA association with GCA, consistent with previously reported associations of classical HLA alleles like HLA-DRB1∗04. An omnibus test on polymorphic amino acid positions highlighted DRβ1 13 (p = 4.08 × 10−43) and HLA-DQα1 47 (p = 4.02 × 10−46), 56, and 76 (both p = 1.84 × 10−45) as relevant positions for disease susceptibility. Outside the HLA region, the most significant loci included PTPN22 (rs2476601, p = 1.73 × 10−6, OR = 1.38), LRRC32 (rs10160518, p = 4.39 × 10−6, OR = 1.20), and REL (rs115674477, p = 1.10 × 10−5, OR = 1.63). Our study provides evidence of a strong contribution of HLA class I and II molecules to susceptibility to GCA. In the non-HLA region, we confirmed a key role for the functional PTPN22 rs2476601 variant and proposed other putative risk loci for GCA involved in Th1, Th17, and Treg cell function

Water-Facilitated Electrodeposition of Neodymium in a Phosphonium-Based Ionic Liquid

Rare-earth metals are considered critical metals due to their extensive use in energy-related applications such as wind turbines and nickel–metal hybrid batteries found in hybrid electrical vehicles. A key drawback of the current processing methods includes the generation of large amounts of toxic and radioactive waste. Thus the efficient recovery of these valuable metals as well as cleaner processing methods are becoming increasingly important. Here we report on a clean electrochemical route for neodymium (Nd) recovery from [P6,6,6,14][TFSI], trihexyltetradecylphosphonium bis(trifluoromethylsulfonyl)amide which is amplified three times by the presence of water, as evidenced by the cathodic current density and thicker deposits. The role of Nd salt concentrations and water content as an additive in the electrochemistry of Nd3+ in [P6,6,6,14][TFSI] has been studied. The presence of metallic neodymium in the deposits has been confirmed by X-ray photoelectron spectroscopy.ELKARTEK 2016, KK-2016/00095, LISO

Platinum group metals recovery using secondary raw materials (platirus): Project overview with a focus on processing spent autocatalyst

PLATInum group metals Recovery Using Secondary raw materials (PLATIRUS), a European Union (EU) Horizon 2020 project, aims to address the platinum group metal (pgm) supply security within Europe by developing novel and greener pgm recycling processes for autocatalysts, mining and electronic wastes. The initial focus was on laboratory-scale research into ionometallurgical leaching, microwave assisted leaching, solvometallurgical leaching, liquid separation, solid phase separation, electrodeposition, electrochemical process: gas-diffusion electrocrystallisation and selective chlorination. These technologies were evaluated against key performance indicators (KPIs) including recovery, environmental impact and process compatibility; with the highest scoring technologies combining to give the selected PLATIRUS flowsheet comprising microwave assisted leaching, non-conventional liquid-liquid extraction and gas-diffusion electrocrystallisation. Operating in cascade, the PLATIRUS flowsheet processed ~1.3 kg of spent milled autocatalyst and produced 1.2 g palladium, 0.8 g platinum and 0.1 g rhodium in nitrate form with a 92‐99% purity. The overall recoveries from feedstock to product were calculated as 46 ± 10%, 32 ± 8% and 27 ± 3% for palladium, platinum and rhodium respectively. The recycled pgm has been manufactured into autocatalysts for validation by end users. This paper aims to be a project overview, an in‐depth technical analysis into each technology is not included. It summarises the most promising technologies explored, the technology evaluation, operation of the selected technologies in cascade, the planned recycled pgm end user validation and the next steps required to ready the technologies for implementation and to further validate their potential.publishedVersio

Platinum group metals recovery using secondary raw materials (platirus): Project overview with a focus on processing spent autocatalyst

PLATInum group metals Recovery Using Secondary raw materials (PLATIRUS), a European Union (EU) Horizon 2020 project, aims to address the platinum group metal (pgm) supply security within Europe by developing novel and greener pgm recycling processes for autocatalysts, mining and electronic wastes. The initial focus was on laboratory-scale research into ionometallurgical leaching, microwave assisted leaching, solvometallurgical leaching, liquid separation, solid phase separation, electrodeposition, electrochemical process: gas-diffusion electrocrystallisation and selective chlorination. These technologies were evaluated against key performance indicators (KPIs) including recovery, environmental impact and process compatibility; with the highest scoring technologies combining to give the selected PLATIRUS flowsheet comprising microwave assisted leaching, non-conventional liquid-liquid extraction and gas-diffusion electrocrystallisation. Operating in cascade, the PLATIRUS flowsheet processed ~1.3 kg of spent milled autocatalyst and produced 1.2 g palladium, 0.8 g platinum and 0.1 g rhodium in nitrate form with a 92‐99% purity. The overall recoveries from feedstock to product were calculated as 46 ± 10%, 32 ± 8% and 27 ± 3% for palladium, platinum and rhodium respectively. The recycled pgm has been manufactured into autocatalysts for validation by end users. This paper aims to be a project overview, an in‐depth technical analysis into each technology is not included. It summarises the most promising technologies explored, the technology evaluation, operation of the selected technologies in cascade, the planned recycled pgm end user validation and the next steps required to ready the technologies for implementation and to further validate their potential.publishedVersio